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It has been well documented that stress has adverse effects on the body and can lead to 
various health issues. Stress has been investigated as a cause for unexplained infertility in 
both men and women. Semen quality is a key indicator of male reproductive health. 
Numerous studies have been done on the effect of stress on semen parameters and an 
association between chronic psychological stress and poor semen parameters have been 
reported. Managing psychological stress can help to improve the health of an individual. In 
order to address the problem it is therefore important to determine if an individual experience 
high levels of stress. This can be established through psychological questionnaires and 
various biomarkers, such as the screening test for time urgency perfectionism (TUP) and 
alpha-amylase in saliva.  
In general, more or less 84% of couples are estimated to conceive naturally within a year. 
The remaining 16% of couples are affected by infertility. Within this group, it is estimated 
that male reproductive factors are the sole cause of one-third of cases and a contributing 
factor in another 20% of cases. Management of chronic stress in female patients has shown 
improved IVF rate of 67% or higher. However, as of yet no study has been performed on 
males to correlate the levels of TUP-stress, alpha-amylase to semen parameters as well as 
other seminal stress markers such as DNA fragmentation and oxidative stress (ROS).  
This study compared TUP-categories (Low, Moderate, High) with respect to semen 
parameters, alpha-amylase levels, age and BMI and investigated if increased alpha-
amylase levels correlate with semen parameters, age and BMI. 
The experiments were performed at Medfem Fertility Clinic in Bryanston Johannesburg and 
the Division of Medical Physiology in the Department of Biomedical Sciences at 
Stellenbosch University. A total of 62 male patients of Medfem Fertility Clinic adhering to the 





Results showed no significant difference between age, semen parameters and alpha-
amylase between TUP categories. Men in the High TUP category had a significant higher 
BMI compared to those in the Low and Moderate categories. No significant correlation was 
found between alpha-amylase, age, BMI and semen parameters. 
This study was unsuccessful in proving a significant relationship between the TUP 
categories, age and semen parameters. The High TUP category did show a significantly 
higher BMI compared to the Low and Moderate TUP groups. This finding confirms that there 
is a link between psychological stress and elevated BMI. Although there was no significant 
difference between the TUP categories with regards to sORP values, the Moderate and High 
categories were both higher than the normal value for sORP in semen. This implies that 
chronic stress leads to elevated levels of oxidative stress in semen. 
No relationship was found between TUP categories and alpha-amylase levels. Although 
both are used to detect chronic stress, the TUP questionnaire is used to detect personality 
types who are prone to chronic stress, whilst salivary alpha-amylase is a biomarker for 
chronic stress and functions in a completely different way. It is possible that whilst both can 
be used to detect chronic stress it is not advised to attempt to establish a relationship 








Daar is goed gedokumenteer dat stress ‘n nadelige uitwerking het op die liggaam wat tot 
verskeie gesondheidskwessies aanleiding kan gee. Ondersoek het aangedui dat stress die 
oorsaak is van ‘n onverklaarbare infertiliteit by beide mans en vrouens. Semen kwaliteit is 
‘n sleutel aanwyser vir manlike reproduktiewe gesondheid. Verskeie studies is uitgevoer op 
die effek van stress op semen parameters, en ‘n assosiasie tussen chroniese sielkundige 
stress en swak semen parameters is gerapporteer. Die bestuur van sielkundige stress kan 
help om die gesondheid van ‘n individu te verbeter. Ten einde die probleem aan te spreek 
is dit derhalwe belangrik om te bepaal of die individu hoë vlakke van stress ervaar. Dit kan 
vasgestel word deur die voltooiing van sielkundige vraelyste en verskeie biomerkers, soos 
die siftingstoets vir tydsbeperkende perfektionisme (TUP) en alfa-amilase in speeksel. 
In die algemeen, ondervind min of meer 84% van paartjies, na raming, natuurlike konsepsie 
binne ‘n jaar. Die oorblywende 16% van paartjies word geaffekteer deur onvrugbaarheid. 
Manlike reproduktiewe faktore is vermoedelik die oorsaak van ongeveer een derde van die 
gevalle en ‘n bydraende faktor tot ‘n verdere 20% met in die groep. Die bestuur van 
chroniese stress in vroulike pasiënte het ‘n verbeterde IVB koers van 67% of hoër aangedui. 
Maar tot nog toe is geen studie op mans onderneem om die vlakke van chroniese stress en 
alfa-amilase op semen parameters asook ander seminale stress merkers soos DNA 
fragmentasie en oksidatiewe stress (ROS) te korreleer nie. 
Hierdie studie vergelyk TUP-kategorieë (Lae, matige, hoë) met betrekking tot semen 
parameters, alfa-amilase vlakke, ouderdom en BMI en ondersoek of verhoogde alfa-amilase 
vlakke korreleer met semen parameters, ouderdom en BMI. 
Die eksperimente is uitgevoer by Medfem Fertility Clinic in Bryanston Johannesburg en die 
Afdeling Mediese Fisiologie en die Departement van Biomediese Wetenskappe van die 
Stellenbosch University https://scholar.sun.ac.za
v 
Stellenbosch Universiteit. ‘n Totaal van 62 mans, almal pasiënte van Medfem Fertility Clinic, 
het deelgenaam aan die studie. 
Resultate het geen beduidende verskil getoon tussen ouderdom, semen parameters en alfa-
amilase tussen TUP kategorieë nie. Mans in die Hoë TUP kategorie het ‘n beduidende hoër 
BMI in vergelyking met die in die Lae en Matige kategorieë. Geen beduidende korrelasie is 
gevind tussen alfa-amilase, ouderdom, BMI en semen parameters nie.  
Die studie was onsukselvol om ‘n beduidende verwantskap te bewys tussen die TUP 
kategorieë, ouderdom en semen parameters. Die BMI van die Hoë TUP groep was 
beduidend hoër as die van die Lae en Matige TUP kategorieë. Dit impliseer ‘n verwantskap 
tussen chroniese stress en vetsug. Alhoewel daar geen beduidende verskil was tussen die 
TUP kategorieë in terme van sORP vlakke nie, was die Matige en Hoë kategorieë beide 
hoër as die normale afsnypunt vir sORP in semen. Dit impliseer dat chroniese stress kan 
aanleiding gee tot verhoogde vlakke van oksidatiewe stress in semen. 
Geen verwantskap was gevind tussen die TUP kategorieë en alfa-amilase vlakke nie. 
Alhoewel beide gebruik word om chroniese stress te identifiseer, word die TUP vraelys 
gebruik om persoonlikheidstipes wat geneig is tot chroniese stress te identifiseer, terwyl die 
speeksel alfa-amilase ‘n biomerker is vir chroniese stress en fungeer op ‘n totaal ander 
wyse. Terwyl albei gebruik kan word om chroniese stress te identifiseer word ‘n poging om 
‘n verwantskap tussen die twee te bepaal nie ondersteun nie omdat die meganisme van 
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Background information and literature overview 
1.1 Chronic stress 
Stress is defined as “a state of mental or emotional strain or tension resulting from adverse 
or demanding circumstances”(1). It has been well documented that stress has detrimental 
effects on the body and can lead to various health issues (1–4). Studies have found anxiety 
can sometimes be related to stress; it can be provoked by the existence of prolonged stress 
and multiple stressors. Anxiety is a state of apprehension and disproportionate responses 
to perceived threats (5). This causes disruption of psychological functioning which in turn 
leads to physiological symptoms such as increased heartbeat, elevated blood pressure, 
sweating or dizziness (5). The focus of this study will be on stress. Generally, stress is 
categorised into two types: Objective/acute (instantaneous) and subjective/chronic or self-
induced (perceived) stress (4). Objective/acute stress is a stress response believed to be 
invariably related to certain events or incidences also referred to as environmental 
experiences or demands (6,7). Triggers such as death of a family member or a friend, crime, 
poverty, war and deadlines can all have an effect on even the most relaxed person. These 
stressors or triggers are induced and originate externally (8). Subjective/chronic or self-
induced stress manifests itself due to the way in which a person thinks or perceives that he 
or she will be able to cope with certain events and demands (6,7). This is also called the 
psychological stress perspective. When environmental demands are perceived to exceed 
an individual’s abilities to cope, the individual subsequently feel stressed and experience an 
accompanying negative emotional response. It is important to note that the perception that 
one is experiencing stress is a consequence of both the interpretation of the meaning of an 





In reaction to these stressors the body responds by activation of physiological systems that 
are mainly responsive to physical and psychological demands. These physiological systems 
and how they are affected by stress will be explored in more details at a later stage. 
Objective stressors or environmental demands leads to a secretion of adrenalin, the 
response is acute and short lived (8). In the event that these systems are activated 
repeatedly or for a prolonged period of time, it can increase the chances of an individual 
developing a wide range of both physical and psychiatric disorders (7). 
A simplified diagram (Figure 1) outlining the integration of environmental demands, 
subjective or perceived evaluations of the stressfulness of a situation and the biological 
responses to said stressors or appraisals i.e. stress responses. 
Figure 1: Integration of stressors or life events and biological responses (Adapted from: Measuring stress: a 
guide for health and social scientists (7)) 
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Personality is “a characteristic way of thinking, feeling, and behaving. Personality embraces 
moods, attitudes, and opinions and is most clearly expressed in interactions with other 
people. It includes behavioural characteristics, both inherent and acquired, that distinguish 
one person from another and that can be observed in people’s relations to the environment 
and to the social group” (9). There are several theorists that have defined different types of 
personality. To name a few: personality types A and B, Myers-Brigs 16 personality types, 
Big Five personality traits and Eysenack’s personality. The consistency of personality types 
across different studies is a challenge. Researchers use different criteria, study different 
population groups, sample sizes, language, culture and method of deriving types (10). Type 
A personality have been by far the most extensive studied personality in health research 
(11). Personalities that are more competitive, highly organised, ambitious, impatient, and 
very aware of time management are labelled Type A, while more relaxed, less neurotic and 
frantic personalities are labelled Type B. This study will focus on Type A personality which 
was first described by Rosenman and Friedman in 1950 (12). Type A individuals often put 
themselves at risk of developing subjective or self-induced stress and have an excessive 
competitive drive. These individuals are easily aggravated and tend to overreact. In addition, 
they may be hostile, see the worst in others, be envious and lack compassion. A constant 
sense of urgency is experienced, and they are very impatient. Type A personalities set 
unrealistic time goals for themselves and when it cannot be met they get frustrated and 
angry. They are always stressed for time and will often try to do more than one task at a 
time. These individuals set high standards for themselves and expect others to be equally 
time-urgent and goal-orientated. If situations feel beyond their control, they tend to get 
stressed. In addition, Type A personalities worry about things that other people might not 
deem important and therefore they create extra stress for themselves (8,12,13).  
Time urgency perfectionism (TUP) stress describes the constant/chronic/subjective stress 





becomes a constant stress. Chronic stress persists over an extended period of time. It 
originates internally and is constantly retained and maintained by the individual (8,14,15). 
The negative effects of chronic stress are well documented; it has been shown to affect 
cardiovascular health (16) and suppress immune function, which may lead to increased 
vulnerability to infections, inflammation, cancers and auto-immune diseases (1,17–19). 
Coping responses to stressors manifesting as behavioural changes may influence disease 
risk, for example people engage in poor health choices: smoking, overeating and excessive 
drinking of alcohol (20,21). In a study done by Groesz et al. (22) they found that: “greater 
reported stress, both exposure and perception, was associated with indices of greater drive 
to eat— including feelings of disinhibited eating, binge eating, hunger, and more ineffective 
attempts to control eating (rigid restraint)”. They further suggest that stress exposure may 
bring about a stronger drive to eat and might promote excessive weight gain (22).  
1.2 The nervous system 
In humans, the nervous system can be divided into the central nervous system (CNS) and 
the peripheral nervous system (PNS). The PNS is further divided in the autonomic nervous 
system (ANS) and the somatic nervous system (SNS) (See Figure 2). The SNS receives 
information from the environment through the sensory organs. Sensory information is then 
relayed to the CNS which subsequently controls the activity of the voluntary skeletal muscles 
(23,24). The ANS controls automatic functioning or involuntary muscles. It is often referred 
to as the “involuntary” nervous system as the control of the organs is not conscious. The 
ANS basically regulates all organs that contain smooth muscle, such as the heart, blood 
vessels, visceral organs and exocrine glands (24). Some of the key visceral processes also 
regulated by the ANS include cardiac output, glandular secretions, reproduction related 
activities, blood flow to specific organs and waste removal (24). The sympathetic and 





systems counteract each other (1). The sympathetic system plays a vital role in the “fight or 
flight” responses which include: increases in heart rate, blood pressure, ventilation, skeletal 
muscle perfusion and dilation of the pupils. The parasympathetic system does exactly the 
opposite of the sympathetic system. Parasympathetic output leads to conservation of energy 
as well as a decrease of the heart rate, blood pressure and ventilation. It furthermore, leads 














In the event that an autonomic imbalance exists, for instance when the sympathetic system 
is hyperactive and the parasympathetic system is underactive, it can cause various 
pathological conditions (25,26). Upon perceiving a stressful stimulus, signals are sent to the 
hypothalamus. The sympathetic adrenomedullary (SAM) pathway is subsequently activated 
and adrenaline and noradrenaline are secreted by the adrenal medulla (1,27). It has been 
proposed that activation of the SAM pathway also leads to increased salivary alpha-amylase 































regulate allostatic load (31). Physiological set points can change in reaction to chronic stress 
in a process called allostasis. A ‘load’ is then produced that may have an additive effect to 
the pathophysiological process, which is involved in a number of chronic illnesses (1,32). 
The functioning of the SNS, Hypothalamus-pituitary-adrenal (HPA) - axis, immune system 
and cardiovascular and metabolic processes are all impacted by this dysregulation of 
physiological systems. In short, allostatic load refers to the total or collective damage caused 
by a repeated neuroendocrine response resulting from chronic stressors, which over an 
extended period of time may lead to deteriorations in health (33). 
Increased cortisol levels are associated with decreased vagal function (1). When the 
perceived stressors manifest as chronic stress, the SAM can remain hyperactive, and the 
HPA-axis is also activated (1,27). The activation of the HPA-axis leads to the release of 
cortisol in the bloodstream (1,27). Excessive secretion of cortisol over a longer period of 
time may lead to increased allostatic load and therefore onset of disease (1). Neural 
structures are damaged by long term cortisol exposure (34). Various conditions or situations 
can result in a chronically activated HPA-axis; this includes melancholic depression, panic 
anxiety and obsessive compulsive disorder (35). 
A multitude of genetic, environment and developmental factors have an influence on the 
effects of the HPA-axis, the SNS and their respective hormones, which are considered to 
be the key components of the “stress system” (36). Dysregulation of the “stress system” will 
cause individuals to suffer adverse health consequences. 
Non-physical events can easily trigger the physiochemical responses of the HPA axis. For 
example: grief, excitement, fear, anxiety, guilt and embarrassment can all trigger a robust 
HPA-axis response. Adrenocorticotropic hormone (ACTH) and cortisol will also be increased 
in most individuals by events such as: public speaking, performance evaluations, and sky 





and recovery to these stressors is based on the individual’s perception rather than the 
stressors themselves” (36).  
Every person has a unique stress response. Some qualities, listed hereunder, further 
individualises each person’s stress response (36): 
• Age 
• Gender 
• Hereditary predisposition 
• Personality characteristics (for example whether a person is an introvert or has low 
self-esteem) 
•  Prenatal and early childhood experiences 
There are four key factors that determine the scale to which the HPA-axis will respond to an 
emotional or mental stressor (37,38): 
1. Novelty to the individual 
2. Unpredictive nature 
3. Threat to the person or ego 
4. Sense of loss of control 
Some individuals might therefore perceive themselves as being stressed based on their 
thinking of how well they are able to cope. While another individual under the same 
“stressful” circumstance might not regard themselves as being stressed. 
1.3 Stress and infertility 
Stress has been investigated as a cause for unexplained infertility in both men and women 
(39–41). Semen quality is a key indicator of male reproductive health (6). Numerous studies 





between chronic psychological stress and poor semen parameters have been reported 
(42,46,47). In a study performed by Gollenberg et al. (47) it was found that individuals who 
experienced two or more stressful life events had a lower sperm concentration and showed 
a decrease in the percentage motile sperm. Janevic et al. (6) similarly reported decreased 
sperm concentration, decreased percentage motile sperm and a decrease in percentage of 
morphologically normal sperm in men suffering from psychological stress. An association 
between higher perceived stress and decreased sperm concentration and normal 
morphology was also found by researchers in China (48).  
As mentioned previously, psychological stress activates certain systems and pathways 
within the body, thereby resulting in hormonal and homeostatic changes. When the HPA 
axis is activated as a result of chronic stress, the activity of the hypothalamic-pituitary-
testicular (HPT) axis is reduced (49). The HPT axis involves releasing of gonadotrophin-
releasing hormone (GnRH) from the hypothalamus, which stimulates the anterior pituitary 
to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH binds to 
the receptors on the Sertoli cells to regulate spermatogenesis, while LH binds to the 
receptors on the Leydig cells to stimulate testosterone production (50). Corticotrophin-
releasing hormone (CRH) released by the hypothalamus with activation of the HPA axis 
inhibits the release of GnRH, resulting in suppression of reproductive functions (51). The 
surplus cortisol that is present in the body as a result of stress can influence the reproductive 
system as the cortisol serves to inhibit GnRH and essentially have a negative impact on 
FSH, LH and testosterone, all of which are needed for healthy spermatogenesis (50,52). 
Some studies have also linked psychological stress and reduction in sperm quality to an 
increase in seminal plasma reactive oxygen species (ROS) generation and a reduction in 
antioxidant protection (53). ROS are also known as oxidants which are highly reactive and 
belong to the free radical class (54). There is a common association between compromised 





oxidative stress develops (55). ROS has a negative impact on sperm function as it can 
decrease sperm concentration and motility and also damage sperm nuclear 
deoxyribonucleic acid (DNA). The sperm plasma membrane contains plentiful 
polyunsaturated fatty acids (PUFAs) and is therefore very sensitive to the effect of ROS. 
These PUFAs play a role in sperm motility and the acrosome reaction which is necessary 
for fertilisation (53). ROS damages the sperm membrane through lipid peroxidation, which 
reduces the motility of the sperm and its ability to fuse with the oocyte. ROS also directly 
damages sperm DNA, compromising the paternal genomic contribution to the embryo 
(50,56). In human spermatozoa the sperm chromatin structure is highly organised to ensure 
that there is no endogenous and exogenous attacks by toxic elements (57). The sperm DNA 
bases can be modified by various physical, chemical and biological factors causing lesions, 
mutations and deletions in the DNA bases. The modification of the DNA base pairs may lead 
to fragmentation and denaturation of the DNA causing reduced sperm function and 
fertilisation potential. Sperm DNA integrity is associated with sperm motility, capacitation, 
the acrosome reaction, normal development of the embryo and birth of healthy offspring. 
The compact packaging of the sperm chromatin is necessary for maintaining sperm DNA 
integrity. Understanding the sperm chromatin structure is necessary and valuable in 
management of infertile men (58,59). From the aforementioned mechanisms it is clear that 
stress can cause or play a role in infertility. 
1.4 Testing for stress 
1.4.1 Psychological questionnaires 
From the preceding information it is clear that stress can have an impact on male fertility 
through various pathways and can have a detrimental effect on semen parameters and male 
reproductive health. Managing psychological stress can help to improve the health of an 





individual experience high levels of stress. This can be established through psychological 
questionnaires and various biomarkers (29,32,47). Psychological questionnaires have been 
used to establish stress levels and personality types for a long time. Studies as early as 
1974 have used psychological questionnaires in stress related studies (60). From the 
literature it is clear that quite a large number of questionnaires exist (61–64). While some 
questionnaires are similar in tone and questions asked, most are compiled with a specific 
outcome in mind related to the study performed. For example, some studies use 
psychological questionnaires to determine work related stress (65), stress among students 
(66), the relationship between psychological stress and testicular function (67), and the link 
between Type 2 diabetes mellitus and psychological stress (68). One such questionnaire is 
a screening test specifically designed for diagnosing TUP stress as was discussed earlier. 
This on-line test will determine if a person falls into any of the three categories of TUP (8). 
These three categories are defined as follows: 
• “Low-TUP refers to a balanced approach in being on time in personal and work 
activities, and performing work and personal activities to a reasonable degree of 
correctness”.  
• “Moderate-TUP refers to a need to be hurried and perfect in the execution of tasks, 
in many, but not all areas of life”.  
• “High-TUP refers to the tendency to be very hard driving in one’s approach to all 
activities including an excessive need to hurry and produce perfect results in all areas 
of activity” (69).  
A copy of the questionnaire can be found in Addendum I. 
1.4.2 Salivary biomarkers 
Salivary biomarkers provide a reliable non-invasive and objective measurement of chronic 





whilst salivary alpha amylase is an indicator of the SAM pathway involved in the stress 
response (6,30). The SAM system is activated when a stressor is perceived; if that stressor 
becomes chronic the HPA axis is activated whilst the SAM pathway remains active as well 
(27). An activated HPA axis cause an increase in blood cortisol levels which leads to an 
increase in salivary cortisol. The SAM system leads to an increase in noradrenaline which 
results in an increase in salivary alpha-amylase production by the parotid gland (27,28). The 
response of HPA and SAM activity after repeated stress was investigated by Schommer and 
co-workers (70). They found that HPA responses adjust quickly, whilst the sympathetic 
nervous system shows consistent activation patterns with repeated stress. These results 
suggest that salivary alpha amylase may be used when assessing chronic stress (70). Nater 
et al. (29) suggest that the two branches of the autonomic nervous system do not act 
independently, therefore both parasympathetic and sympathetic activation lead to an 
increase in alpha-amylase levels. Neurotransmitter stimulation activates secretion from 
salivary glands; these glands are innervated by both the sympathetic and parasympathetic 
nerves. Therefore salivary alpha-amylase is an ideal indicator of autonomic activity (71). 
Bosch et al. (72) found a predominant role of the sympathetic nervous system in the 
secretion process of alpha-amylase, together with vagal withdrawal, under psychosocial 
stress. In a study conducted by Nater et al. (28) in 2004, they found salivary alpha-amylase 
to be a variable that is sensitive to psychosocial stress, displaying pronounced increases 
following induction of stress compared to a rest condition. They concluded that salivary 
alpha-amylase to be a valid and reliable stress marker. Vineetah et al. (32) also found that 
salivary alpha amylase activity increases in patients with chronic psychosocial stress and 
may be used as a biomarker of chronic stress. Cortisol is thought to be the classical 
biomarker of stress (32); however, several studies have failed to find an association between 





and co-workers found in two studies that stress as measured by increased salivary alpha-
amylase is associated with lower fecundity among affected women (27,61).  
Infertility is defined as “a condition in which a couple is unable to conceive, after frequent 
unprotected sexual intercourse, for twelve months or more” (74). In general, more or less 
84% of couples are estimated to conceive naturally within a year. The remaining 16% of 
couples are affected by infertility. Within this group, it is estimated that male reproductive 
factors are the sole cause of one-third of cases and a contributing factor in another 20% of 
cases (53,56). Management of chronic stress in female patients has shown an improved In 
Vitro Fertilisation (IVF) rate of 67% or higher, whereas chronically stressed female patients 
had an average success rate that was comparative to IVF results across the world (8).  
However, as of yet no study has been performed on males to correlate the levels of the TUP 
stress categories, alpha-amylase levels and semen parameters as well as other seminal 
stress markers such as DNA fragmentation and ROS. 
1.5 Research Question 
Does chronic stress (TUP-stress) have a negative effect on semen parameters, age and 
Body Mass Index (BMI) and does alpha-amylase levels in saliva correlate with chronic 
stress (TUP-stress) semen parameters, age and BMI. 
1.6 Aims and Objectives 
Aim: 
To determine the possible relationship, if any, between semen parameters of male 






• Compare TUP-categories (Low, Moderate, and High) with respect to semen 
parameters, alpha-amylase levels, age and BMI. 
• Investigate if alpha-amylase levels correlate with semen parameters, age and BMI. 
1.7 Place of Study 
The experiments were performed at Medfem Fertility Clinic in Bryanston Johannesburg and 
the Division of Medical Physiology in the Department of Biomedical Sciences at 
Stellenbosch University. 
Chapter 2 
Materials and Methods 
2.1 Study method and design 
The study aimed to explore the possible correlation, if any, between semen parameters of 
male individuals, the alpha-amylase saliva test and the TUP- stress test. The outline of the 
study design is depicted in Figure 3. Male patients attending Medfem Fertility Clinic were 
asked to produce a semen sample after which a routine semen analysis as well as a DNA 
fragmentation and Oxidative stress evaluation followed. The routine semen analysis forms 
part of a standard work-up for infertility diagnosis at Medfem Fertility Clinic. A saliva sample, 
for evaluation of the Alpha-amylase levels, was collected and the patients also completed 
the TUP-stress test questionnaire (www.timeurgency.com) (Addendum I). A lifestyle 
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Male patients of Medfem Fertility Clinic adhering to the basic requirements were invited to 
participate in the study. 
Inclusion criteria: 




Trauma to the testes 
Varicocele 





2.3 Semen sample collection 
Semen samples were collected in private rooms at Medfem Fertility Clinic by means of 
masturbation, after 2-3 days of sexual abstinence. Sterile wide-mouthed containers were 
used for collection. Once the sample was produced, it was placed at 37˚C and left to liquefy 
for 30 minutes. Collection of semen samples were completed according to the World Health 
organisation (WHO) guidelines (75). 
2.4 Semen analysis 
Semen samples were evaluated according to standard Medfem Fertility Clinic laboratory 





period. A semen analysis consists of the following evaluations and tests, as described by 
the WHO (75): 
Appearance of the ejaculate 
The semen sample was evaluated macroscopically and the colour and transparency of the 
sample was noted.  
Semen volume 
The semen sample was transferred from the collection container to a graduated tube (Nunc, 
Thermo Scientific, Roskilde, Denmark). The volume was read directly from the graduations. 
Semen pH 
Litmus paper (Merck Millipore®, Massachusetts, United States) was used to measure the 
pH. A drop of semen was placed on a piece of Litmus paper, and once the colour has 
changed uniformly it was compared to the calibration strip. 
Semen viscosity 
The semen sample was drawn up in a 3ml plastic Pasteur pipette (Vitrolife, Göteborg, 
Sweden) where after the semen was allowed to drop by gravity and the length of any thread 
was noted. A normal sample leaves the pipette in small drops. A thread of longer than 2cm 
was regarded as abnormal. 
Antisperm antibodies in the semen 
Antisperm antibodies were tested by the SpermMAR IgG (Fertipro, Beernem, Belgium) test. 
On a micro slide (Lasec®, Cape Town, South Africa) 10µl of semen was mixed with 10ul of 
the latex particles, it was then mixed with 10µl of antiserum. The mixture was covered with 





magnification. The result was read after 2-3 minutes. The mixture was then observed for 
latex particles attached to motile sperm. 
Sperm motility 
A 5µl aliquot of semen was loaded in each chamber of a 2-Chamber 20µm Leja® slide 
(Nieuw-Vennep, The Netherlands). The slide was then examined under 200 x magnification, 
with an eyepiece reticle with a grid. The motility of the spermatozoa was tallied with a 
laboratory counter in each of the following categories: progressively motile, non-
progressively motile and immotile sperm. 
Sperm concentration 
The sperm concentration was evaluated by using a 2-Chamber 20µm Leja® slide. A 5µl drop 
of semen is loaded in each of the 20µm chambers. The slide was then examined 
microscopically under 200 x magnification with an eyepiece reticle with a grid. The grid is 
composed of 10x10 blocks. The number of sperm inside a row of ten blocks was counted 
and noted. A count was done for each of the chambers and an average was calculated. 
Sperm vitality 
The Eosin-Nigrosin dye exclusion staining technique was used to quantify the % of viable 
sperm. A 50µl aliquot was taken from the semen sample and mixed with equal amounts of 
Eosin-Nigrosin (Thermo Scientific™, Massachusetts, United States). A smear was made on 
a glass slide and left to air-dry. The slide was then examined under brightfield optics at 1000 
x magnification under oil immersion. Unstained spermatozoa were classified as live, while 






The Hemacolor® (Merck Millipore®, Massachusetts, United States) staining technique was 
used to evaluate the morphology of the spermatozoa. A 10µl aliquot was taken to make a 
smear on a glass slide. The slide was left to air dry. The slide was then placed in the fixing 
solution for 10 seconds. This was followed by immersing in the Staining Solution-1 for 7 
seconds, and subsequently Staining Solution-2 for 7 seconds. Finally, the slide was rinsed 
in the Buffer Solution. The slide was allowed to air dry. Once the slide was dry, it was 
evaluated under brightfield optics at 1000 x magnification under oil immersion. Sperm 
morphology was evaluated according to the 2010 WHO guidelines (56). Samples with 
normal morphology of ≥4% were reported as “Normal”. Samples with a normal morphology 
of ≤3% were reported as “Abnormal”. 
Chromomycin A3 staining 
CMA3 is a fluorochrome. Mature DNA in sperm shows a low binding capacity for these 
fluorochromes. A 10µl aliquot of semen was taken to prepare a smear. The air-dried slide 
was fixed (3 parts Methanol: 1 part Acetic acid) (Labretoria, Menlo Park, Pretoria) for 20 
minutes. The slide was evaluated under 200 x phase-contrast microscopy. An area 
(approximately 30 spermatozoa per high field magnification) was identified for evaluation; 
where after a small circle was drawn with a diamond point pen to mark the chosen area. 
The CMA3 stain (Labretoria, Menlo Park, Pretoria) (60-100µl) was then applied on the circle 
and left in the dark in the fridge for 20 min. The slide was taken out and washed in McIlvaine’s 
buffer (Labretoria) for 20 seconds, then mounted with a coverslip and Dabco® (Aldrich 
Chemistry, Missouri, United States) mounting solution. It was then stored overnight in the 
fridge (2°C-8°C) where after it was evaluated using Fluorescence Miscroscopy. At least 100 
spermatozoa were evaluated according to the following 4 classes: 
1. No Staining (No Fluorescence) 





3. Fluorescent staining (faintly yellow) 
4. Bright yellow fluorescent staining 
Interpretation of the results: 
Classes 1 and 2 indicate good quality packaging DNA in the sperm head 
Classes 3 and 4 indicate poor packaging DNA in the sperm head 
2.5  Oxidative Stress 
2.5.1 Materials 
Equipment 
• RedoxSYS Analyzer (Aytu Bioscience, Colorado, United States) 
Disposables 
• RedoxSYS Sensors (Aytu Bioscience, Colorado, United States) 
2.5.2 Methods 
• An individual RedoxSYS sensor was unwrapped and placed into the RedoxSYS 
Analyzer 
• Using a pipette, 30µl of semen was transferred to the sample application port of the 
inserted sensor 
• Once detected, the RedoxSYS Analyzer began processing the sample 
• Results was received within 2 minutes 
• Samples were evaluated in duplicate 
2.5.3 Interpretation of results 
• The oxidation reduction potential (sORP) is completed in 2 minutes. Values above 





and antioxidants that favours the oxidants and signify the presence of oxidative stress 
in the specimen 
• The sORP measurement was ‘normalized’ using the sperm concentration in order to 
account for differences in cell count between samples: the sORP (mV/106/ml) was 




• A measurement of 10 mV/106/ml or less was regarded as acceptable between 
duplicate measurements for each sample 
2.6  DNA Fragmentation 
DNA fragmentation was evaluated using the Terminal deoxynucleotidyl transferase dUTP 
nick end labelling (TUNEL) assay with the APO-Direct™ kit from BD Pharmingen (Franklin 
Lakes, United States). An aliquot of the semen sample collected on the day of the semen 
analysis was used for the DNA fragmentation test. 
2.6.1 Materials 
Sperm fixation 
• Centrifuge (300 x g) 
• Serological pipettes 
• Pasteur pipettes 
• 3.7% paraformaldehyde 
• Ice 
• 70% (v/v) ethanol 





• Phosphate-buffered saline (PBS, pH 7.4) 
Staining 
• APO-DIRECT Kit components: Reaction buffer, PI/RNase staining buffer, rinsing 
buffer, wash buffer, Terminal deoxynucleotidyl transferase (TdT) enzyme, 
Fluoroscein isothiocyanate (FITC)-dUTP. Positive and negative control cells. 
• Distilled water 
• Aluminium foil 
Flow cytrometry 
• Flow cytometer equipped with a 488nm Argon laser 
• Flow cytometer data acquisition software 
Fluorescence microscopy 
• Fluorescence microscope (Excitation between 460 and 490 nm and emission >515 
nm) 
• Microscope slides 
• Cover slips 
2.6.2 Methods 
Semen concentration assessment 
• Approximately 2-3 x 106 total cells are sufficient to run the assay. To optimize the 
stains, the sperm concentration should be no more than 5 x 106 
• For efficiency samples were stored at -20˚C and batched for TUNEL analysis.  





• For the positive sperm control, DNA damage was induced by digestion with DNase I. 
A sample form a healthy donor was incubated after the cell counting step with 100µl 
of DNase I (1mg/ml) for 1h at 37˚C 
• Similarly, a sample from a healthy donor was used for the negative sperm control, 
and the TdT enzyme was omitted from the staining step as described below 
Fixation of sperm 
• The fixation buffer was prepared by adding 10ml of 37% formaldehyde (100% 
formalin) to 90ml of PBS (pH 7.4) to give a 3.7% (v/v) paraformaldehyde solution 
• The sperm sample was centrifuged at 300 x g for 7 minutes to pellet and separate 
the cells from the seminal plasma. All subsequent centrifugation steps were done at 
300 x g for 5 minutes 
• The supernatant was discarded by gently aspirating with a Pasteur pipette 
• The cells were suspended in the 3.7% paraformaldehyde fixation buffer. The 
suspension was refrigerated at 4˚C overnight 
• The supernatant was discarded, and the pellet suspended in 1 ml of ice cold 70% 
ethanol at -20˚C 
Preparation of samples for staining 
• All samples (test and controls) were resuspended by vortexing the tubes since the 
cells have settled after prolonged storage in ethanol 
• For the kit controls, a positive and negative control was provided with the APO-
DIRECT kit. 2ml of each of the control suspensions were taken and placed in 12 x 75 
mm centrifuge tubes 






• The cells were resuspended in 1ml of wash buffer, centrifuged at 300 x g for 5 
minutes, and the supernatant removed 
• The Wash Buffer treatment was repeated a second time 
Staining 
• An appropriate volume of the Staining Solution was prepared based on the number 
of samples to be assayed. For each sample analysed the following was combined: 
10µl of Reaction buffer, 0.75µl of TdT Enzyme, 32.25 µl of distilled water, and 8µl 
FITC-dUTP. The FITC-dUTP reagent was added last as it is light sensitive 
• The cell pellets were resuspended in 50µl of the Staining Solution. For negative 
semen controls, staining solution was added without the TdT enzyme 
• To disperse the cells and to allow the staining solution to permeate homogeneously 
into every cell the tube was vortexed 
• The cells were incubated for 60 minutes at 37˚C 
• After incubation, 1.0ml of Rinse Buffer was directly added to each sample, centrifuged 
at 300 x g for 5 minutes, and the supernatant removed by aspiration 
• The rinse step was repeated with additional 1.0ml of Rinse Buffer, centrifuged, and 
the supernatant again removed of each tube 
• The cells were resuspended in 0.5ml of the PI/RNase Staining Buffer and incubated 
at room temperature for 30 minutes 
• The cells were analysed  in the PI/RNase solution within 3h of completing the staining 
procedure using flow cytometry 
Flow cytometry 
• PI stains total DNA, FITC-dUTP stains apoptotic cells. PI is a membrane impermeant 





will be penetrated by the dye. Propidium Iodide (PI) (red) fluoresces at about 623nm 
and FITC (green) at 520nm. Two dual parameter and two single parameter displays 
are created with the flow-cytometer data acquisition software 
2.7 Alpha-amylase salivary ELISA 
The alpha-amylase ELISA assay is an enzyme immunoassay for the quantitative 




• Thermo Scientific™ Multiskan FC Microplate Photometer 
• Serono Diagnostics Vibrax® Lab Shaker 
Disposables 
All the disposables are provided with the kit 
• Coated wells 
• Calibrators and controls 
• Enzyme conjugate 
• Antiserum 
• Sample buffer 
• Wash buffer 
• Chromogen/substrate solution 







A saliva sample was collected from each patient. The patient was provided with a Salivette® 
tube for sample collection. Patients were asked to be fasting from 22h00 the night before 
and abstain from physical exercise on the morning of producing the sample. 
Preparation of the patient samples 
• Patient samples were diluted 1:201 in sample buffer 
• For example, 5µl sample to 1ml sample buffer 
Sample incubation 
• 20µl of the calibrators, controls and diluted patient samples were transferred into the 
individual microplate wells according to the pipetting protocol 
• 100µl of enzyme conjugate solution was added into each of the microplate wells 
• 100µl of antiserum solution was added into each of the microplate wells 
• The microplate wells were covered with protective foil provided and incubated for 60 
minutes on a microplate shaker (400 U/min) at room temperature (18˚C to 25˚C) 
Pipetting protocol 
• The pipetting protocol for microtiter strips 1-4 is an example for the quantitative 
analysis of 24 patient samples (P1-P24) as can be seen in Table 1. 
Table 1: Example of the pipetting protocol for microtiter strips for the quantitative analysis of 24 
patient samples 
 1 2 3 4 5 6 7 8 9 10 11 12 
A C 1 P 1 P 9 P 17         






Washing of the samples 
• The wells were emptied and subsequently washed 3 times using 300µl of working 
strength wash buffer for each wash 
• The wash buffer was left in each well for 30 to 60 seconds per washing cycle, and 
then the wells were emptied 
• After washing, all liquid was thoroughly removed from the microplate by tapping it on 
absorbent paper with the openings facing downwards to remove all residual wash 
buffer 
Substrate incubation 
• 100µl of chromogen/substrate solution was added into each of the microplate wells 
• It was then incubated for 15 minutes at room temperature (18˚C to 25˚C) 
Stopping the reaction 
• 100µl of the stop solution was added into each of the microplate wells in the same 
order and at the same speed as the chromogen/substrate solution was introduced 
Measurement 
C C 3 P 3 P 11 P 19         
D C 4 P 4 P 12 P 20         
E C 5 P 5 P 13 P 21         
F C 6 P 6 P 14 P 22         
G Co1 P 7 P 15 P 23         
H Co2 P 8 P 16 P 24         





• Photometric measurement of the colour intensity was made at a wavelength of 
450nm and a reference wavelength between 620nm and 650nm within 30 minutes of 
adding the stop solution 
• Prior to measuring, the microplate was slightly shaken to ensure a homogeneous 
distribution of the solution 
Calculation of results 
The standard curve from which the alpha-amylase concentration of antibodies in the 
unknown serum samples can be taken was obtained by point-to-point plotting of the 
extinction values measured for the 6 calibration sera against the corresponding units 
(linear/log). “4-parameter logistics” plotting was used for calculation of the standard curve 
by computer. Figure 4 is an example of a typical calibration curve. 
Figure 4: Example of calibration curve 
2.8 Time urgency perfectionism stress questionnaire 
Patients were pre-registered on www.timeurgency.com. Each patient completed the 
questionnaire online. The results were available immediately after completion. Each patient 



























2.9 Body Mass Index 
Body Mass Index (BMI) is a value derived from the mass (weight) and height of a person. 
The BMI is a convenient rule of thumb used to broadly categorize a person as underweight, 
normal weight, overweight, or obese, based on tissue mass (muscle, fat, and bone) and 
height. A Lifestyle questionnaire was completed by each patient (Addendum II). The weight 
(kilograms) and height (meters) were noted on the questionnaire. The BMI of each patient 
was calculated by dividing the body mass by the square root of the body height. 
2.10 Data analysis and statistics 
Data was summarised by TUP-category reporting number (N), mean and median for semen 
parameters, age and BMI. Correlations between the latter and alpha-amylase were 
assessed using Spearman’s rank correlation coefficient (rho). 
TUP-categories were compared with respect to semen parameters, alpha-amylase, age and 
BMI using a one-way analysis of variance (ANOVA). Where data was skewed use was made 
of one-way ANOVA for ranks (Kruskal-Wallis rank test). When significant, pairwise 
comparison of TUP-categories was assessed using Bonferroni adjusted criteria, i.e. 
significant when p<0.05/3=0.017. 
Stata® Statistics/Data analysis Release 15.1 (Statacorp, College Station, Texas, United 




A total of 62 men were enrolled in the study; however, four men had to be excluded due to 





analysis result was available for all 58 remaining participants. Depending on the 
concentration and motility of the sperm, some tests could not be performed as a minimum 
number of sperm is required to obtain an accurate test result; these include sperm vitality 
staining, morphology and CMA3. A total of 47 men successfully completed the online TUP-
test. Of the 47 men, 15 were in the LOW TUP-category, 12 were in the Moderate TUP-
category and most of the men (20) were in the HIGH TUP-Category. Three participants who 
completed the online TUP-test did not have BMI results available. Salivary alpha-amylase 
results were obtained for 56 of the 58 participants as two participants could not produce a 
saliva sample.  
3.1  Relationship between age, BMI, semen parameter values, and Alpha-Amylase 
with TUP-categories 
3.1.1 Age 
From Figure 5 it can be observed that there was no significant difference (p=0.483) detected 
in the age of the mean age of the men stratified according to TUP-category (Low: 















































Men diagnosed with High TUP had a significantly higher BMI (29.62±4.99; p=0.031) 
compared to those in the Low (26.22±4.16) and Moderate (25.89±2.59) groups as can be 












3.1.3 Basic semen parameters 
The relationship between basic semen parameter values with TUP-categories is presented 
in Table 2. There was no statistically significant difference between any of the parameters 
(volume, viscosity, concentration, motility, morphology, sperm vitality and MAR) between 
the TUP-categories. 
Table 2: Comparison of TUP-categories (Low, Moderate, and High) with respect to basic semen 
parameters observed means. 
 




Parameter Low Moderate High 
Volume 
(mL) 























































6.33 (17.16) (15) 3.75 (12.99) (12) 8.75 (18.84) (16)  
0.450† 
TUP=time urgency perfectionism; SD= standard deviation; N= number; ANOVA= analysis of variance; MAR= 
mixed agglutination reaction 
† One-way ANOVA for ranks was employed (Kruskal-Wallis rank test) 
 
The Low TUP category had the highest percentage (46.67%) of normal samples compared 
to the Moderate (33.33%) and the High (25%) TUP categories. Samples were evaluated 
according to the lower reference limits as set out by the WHO (Addendum III). The High 
TUP category had an elevated percentage of abnormal motility (25%) compared to the Low 
(6.67%) and Moderate (8.33%) categories. The remaining number of abnormalities in each 








Table 3: Summary of percentage (%) normal semen samples and number of abnormalities (%) 
within each TUP category. 
 
Low TUP category 
Moderate TUP 
category 
High TUP category 
Number of normal 
samples (%) 
46,67% 33,33% 25% 
Number of 
abnormalities (%): 
   
Astenozoospermia 
(Motility < 32%) 
6,67% 8,33% 25% 
Oligozoospermia 
(Concentration <15 x 
106/mL) 
40% 25% 40% 
Teratozoospermia 
(Morphology < 4%) 
26,67% 25% 30% 
Volume (< 1,5ml) 6,67% 8,33% 5% 
Sperm Vitality 
(< 58%) 
33,33% 25% 30% 
TUP = Time Urgency Perfectionism; % = Percentage 
3.1.4 Advanced semen parameters 





There was no statistically significant difference (p=0.460) between the Low (1.43±1.48), 
Moderate (4.23±10.11) and High (12.12±33.50) TUP-categories with regards to Oxidative 
reduction potential (Figure 7). Both the Moderate and High group means is however above 




From Figure 8 it can be observed that there was no significant difference (p=0.713) between 
the mean CMA3 values of the TUP-categories (Low: 46.53±15.14; Moderate: 42.16±13.83; 
High: 42.83±17.82). The mean of each TUP-category is however higher than the 40% cut-





































Figure 8: Bar graph of the mean CMA3 of each TUP-category 




3.1.4.3 Sperm viability 
There was no significant difference (p=0.384) between the % mean of non-viable sperm of 
each group (Low: 81±10; Moderate: 72±22; High: 67±26) as can be seen in Figure 9. 





















































As can be seen in Figure 10, no significant difference (p=0.391) was found with regards to 
Alpha-amylase between the TUP-categories (Low: 172.71±131.80; Moderate: 
241.18±139.83; High: 182.19±140.13).  
Figure 10: Bar graph outlining the mean Alpha-Amylase value for each TUP-category 
3.2 Correlation between semen parameters, age, BMI and alpha amylase 
The age, BMI and semen parameters were correlated to alpha-amylase using Spearman’s 
rank correlation coefficient (rho). The results are presented in Table 4. No significant 
correlation was found between any of the parameters and alpha amylase. However, it was 
interesting to observe that volume showed a negative correlation with alpha-amylase which 
was nearing significance. Correlation figures can be found in Addendum IV. 
Table 4: Spearman rank correlation of semen parameters, age and BMI with alpha-amylase 
level 
Parameter Spearman’s* rank 
correlation coefficient 
P-value 






























BMI 0.119 0.399 
Volume -0.188 0.170 
Viscosity -0.021 0.877 
Concentration 0.217 0.111 
Motility 0.097 0.482 
Morphology 0.186 0.208 
CMA3 0.112 0.422 
Sperm Vitality 0.038 0.806 
MAR 0.167 0.243 
Oxidative Stress 0.046 0.753 
PI 0.047 0.740 
BMI= body mass index; CMA3= chromomycin A3; MAR= mixed agglutination reaction; PI= propidium iodide 
* Spearman’s rho 
 
Chapter 4 
Discussion and conclusion 
Chronic stress is documented to have detrimental effects on the body and can lead to 
various health issues. It is a constant stress and persists over an extended period of time. It 
originates internally and is constantly retained and maintained by the individual. TUP stress 
describes the constant/chronic stress these individuals subject themselves to. There are 
three categories of TUP-stress in which a person can fall, namely Low, Moderate and High. 
The exact classification can be determined by the TUP online questionnaire. 
Chronic stress has been investigated as a cause for unexplained infertility in numerous 





semen parameters. It is estimated that male reproductive factors are the cause of one-third 
of infertility cases (42,46). 
Participants of the study were male patients attending Medfem Fertility Clinic seeking 
assistance with infertility troubles as part of couple infertility. This study attempted to 
establish if there is a possible relationship between various anthropometric measures (e.g. 
age, BMI) the stress marker alpha-amylase, semen parameters and the TUP test.  
Relationship between age, BMI, semen parameter values, and Alpha-Amylase with 
TUP-categories 
Of the 58 participants a total of 47 men successfully completed the online TUP-test. Fifteen 
(31.91%) of these men were classified to fall in the Low TUP-category, 12 (25.53%) were in 
the Moderate TUP-category and 20 (42.55%) were in the High TUP-category. Of interest is 
the fact that the majority of the men who participated in the study (65%), fell in either the 
Moderate or High TUP-categories. Therefore most of the participants reported themselves 
as being stressed. The risk of depression, anxiety and distress is high for infertile patients 
(76). Most studies relating to stress and infertility report high anxiety, depression and stress 
rates among the participants (77,78). In a study in Northern California, 352 women and 274 
men attending Infertility clinics were assessed. It was determined that 56% of the women 
and 32% of the men reported significant symptoms of depression. Furthermore 76% of the 
women and 61% of the men reported significant symptoms of anxiety (77). A review by de 
Berardis et al. (79) concludes that 25 to 60% of infertile individuals report psychiatric 
symptoms and their levels of anxiety and depression are significantly higher than fertile 
controls. Chronic stress is an omnipresent and increasing cause for concern in the modern 
world (80). As discussed earlier, some personality types are more prone to stress (Type A, 
Moderate and High TUP) than others while some cope better than others. Some drive an 





or seek fertility treatment are more stressed than people who do not suffer from infertility 
(6,81,82). Infertile couples experience a wide range of physical and emotional stress during 
their attempts to conceive a child (83). Providing a sufficient semen sample is only one of 
many concerns of a male patient seeking help for infertility. Sexual infertility stress among 
men is often linked with feelings of reduced masculinity and a perceived threat to the male 
identity (84). However, the relationship between stress and infertility may not have a clear 
cause and effect path. In a 2018 review article by Rooney and Domar, they state that while 
it is clear that infertility causes stress it is not clear whether stress causes infertility (76). The 
TUP questionnaire is designed to detect certain personality types, who subject themselves 
to chronic stress. Therefore, although infertility can cause stress, the questionnaire is able 
to exclude acute stressors as well as episodes of stress and focus on detecting chronic 
stress and certain personality types (Moderate and High TUP) who are prone to chronic 
stress. In this study it is therefore implied that men categorised within the Moderate and High 
TUP categories are chronically stressed and therefore this might lead to infertility. 
Although the relationship between age and chronic stress was not one of the main aims of 
this study, it was interesting to see there was no significant difference in the mean age 
between the categories. There are no consistent data for chronic stress and age. Some 
studies report a decrease in chronic stress with increasing age while others show no 
difference between younger and older adults (85). 
Men in the High TUP category had a significant higher BMI compared to those in the Low 
and Moderate groups. The World Health Organisation (WHO) categorises the BMI ranges 
















All three TUP categories are therefore in the overweight BMI category with the High TUP 
category borderline Obese Class I. There are numerous studies to suggest that people tend 
to make poor health choices the more they are stressed (22,87–89). It is however not 
necessary to overt psychiatric problems to use comfort food for consolation when feeling 
down and out according to Dallmann et al. (90). In highly developed countries this is a well-
recognised and general incidence, with an epidemic of obesity as a consequence. Stress 
can trigger relapse into obesity. Stress may also be a component of a wide range of obesity 
risk factors as identified by Keith et al. (91) and therefore could contribute to the increasing 
incidence of obesity. The high risk for weight gain, and particular accumulation of visceral 
adipose tissue, during chronic stress is thought to be related to activation of the HPA-axis, 
sympathoadrenal activity as well as a negative emotional consequence (negative mood 
causing ‘emotional eating’) (92). These findings may indicate that men within the High TUP 
category might be borderline obese Type I due to their high stress levels that may lead to 
obesity. Tomiyama et al. (93) also found significantly greater BMI in the high stress group 
Table 5: Categories of BMI ranges 
Category BMI Range (kg/m2) 
Severe thinness <16 
Moderate thinness 16-17 
Mild thinness 17-18.5 
Normal 18.5-25 
Overweight 25-30 
Obese Class I 30-35 
Obese Class II 35-40 
Obese Class III >40 





and reported greater eating after stressful events. A very early theory of obesity by Kaplan 
and Kaplan in 1957 proposed that obese people overeat when anxious and eating reduces 
this anxiety, thus eating in order to reduce anxiety may lead to compulsive overeating and 
obesity (94). A problem of using BMI as an indicator of obesity is that the BMI measurement 
does not differentiate between body lean mass and body fat mass. Gurevich et al. (95) 
studied the obesity prevalence and accuracy of BMI-defined obesity in Russian firefighters. 
Their concern was that because of the nature of their duties, firefighters might have greater 
muscle mass at any given BMI. They also examined the accuracy of BMI-based obesity 
compared to body fat percent (BF %) and waist circumference (WC). Comparing BMI to 
analogous BF% and WC categories resulted in low rates of false positives, (3 and 6%), but 
relatively high rates of false negatives (65 and 36%). They therefore concluded that the use 
of BMI for determining obesity is realistic but could be improved easily with WC if there are 
concerns about omitting firefighters with high abdominal adiposity even though they are not 
obese based on BMI (95). In a review article on BMI by Frank Nuttal (96), he states that BMI 
is a poor indicator of percent body fat and it does not capture information on the mass of fat 
in different body sites. However, according to Malina and Katzmarzyk (97), the BMI is a 
suitable and valid indicator of the risk of overweight and the presence of overweight in 
adolescents. They further state that the BMI is only a screening tool; adolescents identified 
as being at risk of overweight or as overweight should be referred for appropriate 
counselling. It has however been suggested that central obesity measures such as WC, 
waist to height ratio (WHtR) and waist to hip ratio (WHR) are superior to BMI in predicting 
visceral adiposity, mortality and cardiometabolic disease (98,99).  
There was no significant relationship between any of the basic semen parameters and TUP 
categories. Although there are numerous studies that found a negative effect of chronic 
stress on semen analysis outcome, this was not seen in this study. The studies all utilised 





based on the outcome in mind, accessibility and ease of use of the questionnaire. The TUP-
stress questionnaire was developed and used for this study for the same reasons. This could 
have lead to the difference in outcome between this study and previous studies, due to 
different stress questionnaires used in each study. In 2010 the WHO revised the normal 
reference values for semen analysis which have lower cut-off compared to the 1999 WHO 
which was used for the interpretation of semen analysis up until that point. Consequently 
several men who, based on their semen analysis were previously diagnosed abnormal, have 
now become normal using new reference values. In a study by Alshahrani et al. (100) they 
found that 19% of the population studied changed classification from abnormal to normal 
when all normal semen parameters were considered. Of the total, 661.44% of the population 
changed its classification from abnormal to normal when at least one or more abnormal 
semen parameter was examined. Therefore, this study might have found an effect on semen 
parameters should the 1999 WHO reference values have been used. However, more recent 
studies have used the WHO 2010 reference values and did find a negative effect on semen 
parameters due to chronic stress (49,67). Interestingly in a study by Nouri et al. (101) in 
2014 on the decline of semen quality during IVF and subjective male stress, they utilised 
the WHO 1999 reference values and did not find a decline in semen quality. Our findings 
are similar to those of Clarke and colleagues (83) in a study done in 1999. They tested the 
relationship between psychological stress and semen quality among in-vitro fertilization 
patients and found no correlations between perceived stressfulness and any of the sperm 
parameters measured pre-IVF. The semen analysis results of the current study were all pre-
IVF evaluations and participants were first time patients of the clinic. Only one semen 
sample was obtained for each man. Subsequent samples produced for IVF purposes were 
not included in this study. It is possible that this could have lead to misclassification of 





effects of stress. However, one semen sample is considered sufficient to assess semen 
quality (102). 
ORP also known as redox potential, has recently been introduced as a single measure of 
oxidative stress (103). There was no significant difference between the TUP categories with 
regards to ORP. Two separate studies have identified an ORP value of > 1.36 mV/106/mL 
and 1.42 mV/106/mL as the cut-off value to differentiate infertile from fertile men (104,105). 
Both the Moderate (4.23±10.11) and the High (12.12±33.50) TUP categories are above the 
normal range stipulated. This implies a change in the balance between oxidants and 
antioxidants that favours the oxidants and signifies the presence of oxidative stress in the 
specimen. It is known that stress increases ROS in the male reproductive tract. 
Psychological stress can influence oxidative stress and male infertility (106). A main reason 
for infertility is believed to be excessive production of ROS or decreased antioxidant capacity 
in semen that causes oxidative stress conditions and ultimately a decrease in sperm motility, 
increase in sperm death, and fragmentation of DNA (107,108). Low physiological amounts 
of ROS are however required to trigger essential sperm functions such as capacitation, 
hyperactivation, acrosome reaction, and sperm-oocyte fusion (109). Although no significant 
difference between TUP categories were observed, it is interesting that both the Moderate 
and High TUP categories are above the cut-off value. This could imply that oxidative stress 
does increase in semen samples due to an increase in chronic stress. Factors that might 
have influenced the outcome of this test are semen viscosity and sample size. It was 
observed that samples that had high viscosity did not have an accurate sORP reading 
(duplicate sensors with completely different results) or the MiOXSYS analyser simply read 
error. These results had to be excluded from the statistical analysis. In a clinic trial involving 
the MiOXSYS analyser, semen samples that have not liquefied within 60 minutes were 
excluded from the study (110). Furthermore, the clinical trial as well as a study by Homa et 





According to the authors ROS and sORP measurement are inaccurate and unreliable when 
the sperm concentration falls below this value. The current study did not exclude patients 
with a concentration lower than 1 x 106/mL. Two patients had a concentration of 0.1 x 106/mL 
and one had a concentration of 0.2 x 106/mL. Interestingly all three these participants were 
in the High TUP category. 
Although there was no significant difference between the mean sperm chromatin packaging 
(CMA3 analysis) values of the groups, it is interesting to note that all the mean values were 
higher than the cut-off value of 40%.  
Propidium Iodide is a vital dye that tests for cell viability via dye-exclusion. There was no 
significant difference between the mean values of PI between the TUP-categories. The Low, 
Moderate and High TUP categories showed a percentage of 81%, 72% and 67% non-viable 
cells respectively. During the process of apoptosis, one of the earliest events is the 
disturbance of the asymmetry of the bilayer of the cell membrane. The most characteristic 
feature, but a relatively late phenomenon in the apoptosis-cascade, is activation of an 
endogenous endonuclease, which generates numerous DNA double strand breaks in 
chromatin (112). The TUNEL assay includes FITC staining for DNA fragmentation but was 
not reported in the results, as the % of cells affected were nearing 0%. This could imply that 
some of the cells could have been in the early stages of apoptosis (disturbance of the cell 
membrane) but DNA damage have not yet occurred.  
There was no significant difference with regards to alpha-amylase between the TUP 
categories. The measurement of salivary alpha-amylase activity has been proposed to 
reflect stress-related changes in the autonomic nervous system (113,114). In a study 
performed by Nater et al. (115) in 2006 wherein they studied the determinants of diurnal 
course of salivary alpha-amylase, they found no association between stress scores and 





higher with more chronic stress and stress reactivity. All alpha-amylase samples in the 
current study were collected between 8am and 12am, yet no significant difference was 
observed between the TUP categories. Although there is no significant difference in alpha-
amylase levels between the TUP categories it is interesting that the mean value of each 
TUP category is above the normal reference value of the test kit used (DRG Instruments, 
Marburg, Germany). This can possibly be due to increased stress levels in patients who are 
due for an infertility evaluation or the idea of taking part in a research study; however in the 
same study by Nater et al. (115) they found no impact on salivary alpha-amylase levels by 
perceived stress and momentary daily stress. Furthermore, alpha-amylase have been 
proven to be a reliable biomarker of chronic stress (30,32,116). The TUP questionnaire is 
used to identify personality types who subject themselves to chronic stress (Moderate and 
High types). However, this is but one of many personality and chronic stress questionnaires 
that can be used (117–122). It is possible that this specific questionnaire is not sensitive 
enough in identifying chronic stress and that some patients might be incorrectly categorised 
within a certain TUP group. There is also the possibility that patients do not answer the 
questions honestly, some might have been in a hurry and did not think the questions through 
before answering. In a study by Martin et al. (123) they attempted to establish how effective 
people are at faking on personality questionnaires and concluded that their findings indicates 
that the participants were able to falsify the normative scale in the desired direction (123). 
Correlation between semen parameters, age, BMI and alpha amylase 
No correlations between semen parameters, age, BMI and alpha amylase levels were 
observed. There was however a negative correlation between alpha-amylase and semen 
volume which did near significance. Giblin et al. (45) reported the same finding in their study 
entitled: Effects of stress and characteristic adaptability on semen quality in healthy men. In 
their study they also found a negative correlation with the semen measure of volume, and 





an association between stress scores above the reference level and significantly lower 
semen volume (67). It is not clear what mechanism is involved in the negative correlation 
between chronic stress and semen volume. The volume of the ejaculate is contributed 
mainly by the seminal vesicles and prostate gland with a small amount from the 
bulbourethral glands and epididymides. The ANS is often referred to as the “involuntary” 
nervous system as the control of the organs is not conscious. Some of the key visceral 
processes also regulated by the ANS include glandular secretions and reproduction related 
activities (24). The sympathetic and parasympathetic systems are the two subdivisions of 
the ANS (1,23,24). These two sub-systems counteract each other (1). The sympathetic 
system plays a vital role in the “fight or flight” responses which include: increases in heart 
rate, blood pressure, ventilation, skeletal muscle perfusion and dilation of the pupils. The 
parasympathetic system does exactly the opposite of the sympathetic system. Is it possible 
that elevated chronic stress can keep the body in a constant state of ‘fight or flight’? 
Therefore it is speculated that the parasympathetic system attempts to counteract the 
sympathetic system and that the constitutive increased parasympathetic output might 
impact accessory gland secretion and be responsible for the decreased semen volume. 
Conclusion 
To our knowledge this is the first study to compare Time urgency perfectionism stress with 
salivary alpha-amylase levels, age, BMI and semen parameters. The study was 
unsuccessful in proving a significant relationship between the TUP categories, age and 
semen parameters. The High TUP category did show a significantly higher BMI compared 
to the Low and Moderate TUP groups. This finding confirms that chronic stress may lead to 
obesity. Although there was no significant difference between the TUP categories with 
regards to sORP values, the Moderate and High categories were both greater than the 





of oxidative stress in semen which has been proven to compromise semen quality and as a 
result lower male fertility. 
No relationship was found between TUP categories and alpha-amylase levels. Although 
both are used to detect chronic stress, the TUP questionnaire is used to detect personality 
types who are prone to chronic stress, whilst salivary alpha-amylase is a biomarker for 
chronic stress and functions in a completely different way. It is possible that whilst both can 
be used to detect chronic stress it is not advised to attempt to establish a relationship 
between the two as the mechanisms of both are very different. 
The TUP questionnaire is a useful and easy-to-use chronic stress indicator which can be 
used to identify prone-to-stress personality types. Once identified, these patients can be 
assisted with stress management by means of a 10 week stress management course 
available from www.timeurgency.com. This might be helpful to obese patients who overeat 
due to high levels of chronic stress as well as patients who would like to reduce their chronic 
stress levels to possibly improve their fertility.  
Study limitations 
 
A shortcoming of this study is that only one type of obesity parameter (i.e BMI) was utilised. 
It has been suggested that central obesity measures such as WC, WHtR and WHR are 
superior to BMI in predicting visceral adiposity, mortality and cardiometabolic disease. 
In 2010 the WHO revised the normal reference values for semen analysis. The current cut-
off reference values, which were used for the interpretation of semen analysis in this study, 
are much lower compared to the 1999 WHO guidelines. Consequently several men, who 
were previously diagnosed as abnormal, based on their semen analysis, are now classified 





might have found an effect on semen parameters should the 1999 WHO reference values 
have been used as more men might have fallen below the reference values. 
There are several chronic stress questionnaires which are used in a number of different 
studies to detect chronic stress. Therefore the TUP-stress questionnaire might not be best 
suited to correlate with salivary alpha-amylase as there might be another chronic stress 
questionnaire which will be able to show a correlation between a perceived stress 
questionnaire and a salivary biomarker. This however requires further investigation. 
If the Moderate and High TUP categories were pooled and compared to the Low TUP 
category it is possible that statistically significant difference might have been observed. 
However this was not done and can be regarded as a shortcoming of this study. 
Another limitation to this study was the small sample size. Various male patients were 
approached to participate, however several stated that they did not have enough time on 
the day of visiting the clinic to partake in the study. Others did show interest to participate 
but did not complete the TUP questionnaires when asked. 
Many men who participated in this study suffered from infertility. Therefore, it is possible that 
even if they were not stressed, their spermatozoa might already be compromised due to 
other factors, thereby making it difficult to differentiate between stress induced and other 
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Chapter 5  
Addenda 
 
















Name and surname:   ______________________________________ 
Medfem file no:    _____________________________________ 
Cellphone number:  ______________________________________ 
E-mail address:  ______________________________________ 
 
Medical History 
Abstinence period: _________________ (preferably 3-4 days) 
Medication:   _________________ 
Age:   _________________ 
Weight:  _________________ 
Length:  _________________ 






1. Do you smoke? If so, please specify brand and how many daily? 





Brand:  _______________________________________ 
 
2. Do you consume any alcoholic beverages? (e.g. 1 glass of wine/ 1 beer/ 1 tot or 
ale/ 25ml spirit) If so, how many units a day/week? 





3. Have you consumed any alcoholic beverages in the past 72 hours? If so, how 
much? 
Yes  No  Quantity  
 
4. Do you follow a regular exercise programme? If yes, please specify the type of 
exercise and how many times weekly? 






5. Have you exercised in the last 72 hours? If so, please specify the type of exercise. 
Yes  No  
Type: ________________________________________ 
 
6. Do you suffer from any chronic diseases? If so, what kind of disease and when 
were you first diagnosed? 






Date first diagnosed: ____________________________ 
 
7. Are you using any prescription medication? If yes, what is it called and since when 
have you been using it? 
Yes  No  
Name of medication: __________________________________ 
Month and year:   __________________________________ 
 
8. Are you taking any alternative medication, vitamins or mineral supplements, herbal 
or traditional remedies? If yes, specify the name of medication and how often you 
use it. 






9. Have you gained or lost more than 5kg in the past 12 months? If so, how much? 
Yes  No  kg  
 
10. Do you suffer from stress related disorders, such as tension headaches / panic 
attacks / anxiety? If yes, what symptoms and how often per week? 










11. Are you exposed to hazardous chemicals on a daily basis (at work or at home)? If 
yes, where do you work (type of industry) or live (suburb)? 






12. How many meals a day do you eat? 
 Meals per day 
 
13. Do you follow a healthy diet? 
Yes  No  
 




 Occasionally  Never  
 













Addendum III: Lower reference values (5th centiles and their 95% confidence 
















Parameter  Lower reference limit 
Semen volume (ml) 1.5 (1.4–1.7) 
Total sperm number (106 per ejaculate) 39 (33–46) 
Sperm concentration (106 per ml) 15 (12–16) 
Total motility (PR + NP, %) 40 (38–42) 
Progressive motility (PR, %) 32 (31–34) 
Vitality (live spermatozoa, %) 58 (55–63) 
Sperm morphology (normal forms, %) 4 (3.0–4.0 
Other consensus threshold values  
pH ≥7.2 












Addendum IV: Correlation Figures 
 
  Figure a: Correlation between age and alpha-amylase (Spearman’s rho=0.104; p=0.4502) 
Figure b: Correlation between BMI and alpha-amylase (Spearman’s rho=0.119; p=0.399) 
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Figure c: Correlation between semen volume and alpha-amylase (Spearman’s rho= -0.188; p=0.170) 
Figure d: Correlation between semen viscosity and alpha-amylase (Spearman’s rho= -0.021; p=0.877) 
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Figure e: Correlation between concentration and alpha-amylase (Spearman’s rho= 0.217; p=0.111) 
Figure f: Correlation between Motility and alpha-amylase (Spearman’s rho=0.097; p=0.482) 
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Figure g: Correlation between sperm vitality and alpha-amylase (Spearman’s rho= 0.038; p=0.806) 
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Figure i: Correlation between morphology and alpha-amylase (Spearman’s rho= 0.186; p=0.208) 
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Figure l: Correlation between sperm non-viability and alpha-amylase (Spearman’s rho= 0.047; p=0.740) 
Figure k: Correlation between oxidative stress and alpha-amylase (Spearman’s rho=0.046; p=0.753) 
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